- Home
- DCOM vs TVTX Comparison
DCOM vs TVTX Comparison
Compare DCOM & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCOM
- TVTX
- Stock Information
- Founded
- DCOM 1864
- TVTX 2008
- Country
- DCOM United States
- TVTX United States
- Employees
- DCOM N/A
- TVTX N/A
- Industry
- DCOM Major Banks
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- DCOM Finance
- TVTX Health Care
- Exchange
- DCOM Nasdaq
- TVTX Nasdaq
- Market Cap
- DCOM 1.5B
- TVTX 1.8B
- IPO Year
- DCOM 1996
- TVTX N/A
- Fundamental
- Price
- DCOM $30.59
- TVTX $21.98
- Analyst Decision
- DCOM Strong Buy
- TVTX Strong Buy
- Analyst Count
- DCOM 5
- TVTX 12
- Target Price
- DCOM $34.00
- TVTX $30.08
- AVG Volume (30 Days)
- DCOM 270.9K
- TVTX 1.9M
- Earning Date
- DCOM 01-23-2025
- TVTX 02-20-2025
- Dividend Yield
- DCOM 3.27%
- TVTX N/A
- EPS Growth
- DCOM N/A
- TVTX N/A
- EPS
- DCOM 0.55
- TVTX N/A
- Revenue
- DCOM $277,986,000.00
- TVTX $233,175,000.00
- Revenue This Year
- DCOM N/A
- TVTX $62.88
- Revenue Next Year
- DCOM $15.62
- TVTX $57.60
- P/E Ratio
- DCOM $55.62
- TVTX N/A
- Revenue Growth
- DCOM N/A
- TVTX 60.55
- 52 Week Low
- DCOM $17.29
- TVTX $5.12
- 52 Week High
- DCOM $37.60
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- DCOM 42.22
- TVTX 53.52
- Support Level
- DCOM $30.42
- TVTX $22.48
- Resistance Level
- DCOM $32.12
- TVTX $23.69
- Average True Range (ATR)
- DCOM 1.27
- TVTX 1.22
- MACD
- DCOM -0.12
- TVTX -0.02
- Stochastic Oscillator
- DCOM 31.11
- TVTX 41.10
About DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.